El-Heneidy, Asmaa, et al. “Nirsevimab Provides Age-Specific Protection Against RSV Hospitalisation in the First Year of Life: A Population-Level Study in Queensland, Australia”. Communicable Diseases Intelligence, vol. 50, Oct. 2026, doi:10.33321/cdi.2026.50.066.